Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionMonetary Management Group Inc
Latest Disclosed Ownership12,850 shares
Latest Disclosed Value $ 779,352
Monetary Management Group Inc reports 0.43% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 13, 2026 - Monetary Management Group Inc filed a 13F-HR form disclosing ownership of 12,850 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $673,597 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 12,905 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.43% during the quarter. The current value of the position is $609,540 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Bristol-Myers COM 110122108 12,850 -55 -0.43 779 11.93 0.1861
2026-02-11 2025-12-31 13F Bristol-Myers COM 110122108 12,905 -2,500 -16.23 696 0.29 0.1610
2025-11-12 2025-09-30 13F Bristol-Myers COM 110122108 15,405 -1,000 -6.10 695 -8.56 0.1595
2025-08-14 2025-06-30 13F Bristol-Myers COM 110122108 16,405 -500 -2.96 759 -26.38 0.1869
2025-05-14 2025-03-31 13F Bristol-Myers COM 110122108 16,905 0 0.00 1,031 7.85 0.2786
2025-02-13 2024-12-31 13F Bristol-Myers COM 110122108 16,905 -750 -4.25 956 4.71 0.2484
2024-11-13 2024-09-30 13F Bristol-Myers COM 110122108 17,655 -1,645 -8.52 913 13.98 0.2348
2024-07-16 2024-06-30 13F Bristol-Myers COM 110122108 19,300 -100 -0.52 802 -23.86 0.2119
2024-05-13 2024-03-31 13F Bristol-Myers COM 110122108 19,400 -725 -3.60 1,052 1.94 0.2931
2024-02-14 2023-12-31 13F Bristol-Myers COM 110122108 20,125 -3,650 -15.35 1,033 -25.16 0.3221
2023-11-09 2023-09-30 13F Bristol-Myers COM 110122108 23,775 -3,042 -11.34 1,380 -19.54 0.4600
2023-08-11 2023-06-30 13F Bristol-Myers COM 110122108 26,817 -2,075 -7.18 1,715 -14.39 0.5256
2023-05-11 2023-03-31 13F Bristol-Myers COM 110122108 28,892 3,000 11.59 2,003 7.52 0.5893
2023-02-13 2022-12-31 13F Bristol-Myers COM 110122108 25,892 -750 -2.82 1,863 -1.69 0.5817
2022-11-14 2022-09-30 13F Bristol-Myers COM 110122108 26,642 -100 -0.37 1,894 -8.01 0.6242
2022-08-11 2022-06-30 13F Bristol-Myers COM 110122108 26,742 0 0.00 2,059 5.43 0.6454
2022-05-12 2022-03-31 13F Bristol-Myers COM 110122108 26,742 -875 -3.17 1,953 13.41 0.5173
2022-02-14 2021-12-31 13F Bristol-Myers COM 110122108 27,617 1,425 5.44 1,722 11.10 0.4260
2021-11-12 2021-09-30 13F Bristol-Myers COM 110122108 26,192 2,250 9.40 1,550 -3.12 0.4262
2021-08-12 2021-06-30 13F Bristol-Myers COM 110122108 23,942 -12,470 -34.25 1,600 -30.40 0.4822
2021-05-17 2021-03-31 13F Bristol-Myers COM 110122108 36,412 -8,500 -18.93 2,299 -17.48 0.7231
2021-02-12 2020-12-31 13F Bristol-Myers COM 110122108 44,912 100 0.22 2,786 3.11 0.9180
2020-11-12 2020-09-30 13F Bristol-Myers COM 110122108 44,812 -3,345 -6.95 2,702 -4.59 0.9626
2020-08-13 2020-06-30 13F Bristol-Myers COM 110122108 48,157 1,070 2.27 2,832 7.89 1.0702
2020-05-14 2020-03-31 13F Bristol-Myers COM 110122108 47,087 3,850 8.90 2,625 -5.41 1.1617
2020-02-13 2019-12-31 13F Bristol-Myers COM 110122108 43,237 -9,933 -18.68 2,775 2.93 1.0142
2019-11-12 2019-09-30 13F Bristol-Myers COM 110122108 53,170 12,225 29.86 2,696 45.18 1.0207
2019-08-13 2019-06-30 13F Bristol-Myers COM 110122108 40,945 -1,789 -4.19 1,857 -8.93 0.7132
2019-05-14 2019-03-31 13F Bristol-Myers COM 110122108 42,734 600 1.42 2,039 -6.89 0.8072
2019-02-13 2018-12-31 13F Bristol-Myers COM 110122108 42,134 -500 -1.17 2,190 -17.26 0.9896
2018-11-13 2018-09-30 13F Bristol-Myers COM 110122108 42,634 275 0.65 2,647 12.93 1.0110
2018-08-13 2018-06-30 13F Bristol-Myers COM 110122108 42,359 -100 -0.24 2,344 -12.73 0.9562
2018-05-14 2018-03-31 13F Bristol-Myers COM 110122108 42,459 0 0.00 2,686 3.23 1.1135
2018-02-14 2017-12-31 13F Bristol-Myers COM 110122108 42,459 600 1.43 2,602 -2.47 1.0486
2017-11-13 2017-09-30 13F Bristol-Myers COM 110122108 41,859 -75 -0.18 2,668 14.16 1.1249
2017-08-14 2017-06-30 13F Bristol-Myers COM 110122108 41,934 -100 -0.24 2,337 2.23 0.9550
2017-05-15 2017-03-31 13F Bristol-Myers COM 110122108 42,034 -3,000 -6.66 2,286 -13.15 0.9940
2017-02-13 2016-12-31 13F Bristol-Myers COM 110122108 45,034 20,235 81.60 2,632 96.86 1.2160
2016-11-10 2016-09-30 13F Bristol-Myers COM 110122108 24,799 9,325 60.26 1,337 17.49 0.6185
2016-08-12 2016-06-30 13F Bristol-Myers COM 110122108 15,474 -25 -0.16 1,138 14.95 0.5294
2016-05-11 2016-03-31 13F Bristol-Myers COM 110122108 15,499 -50 -0.32 990 -7.48 0.4813
2016-02-11 2015-12-31 13F Bristol-Myers COM 110122108 15,549 -350 -2.20 1,070 13.71 0.5124
2015-11-25 2015-09-30 13F Bristol-Myers COM 110122108 15,899 -2,050 -11.42 941 -21.19 0.4707
2015-08-11 2015-06-30 13F Bristol-Myers COM 110122108 17,949 1,550 9.45 1,194 12.85 0.5386
2015-05-12 2015-03-31 13F Bristol-Myers COM 110122108 16,399 -150 -0.91 1,058 8.29 0.4669
2015-02-12 2014-12-31 13F Bristol-Myers COM 110122108 16,549 -600 -3.50 977 11.28 0.4339
2014-11-06 2014-09-30 13F Bristol-Myers COM 110122108 17,149 1,750 11.36 878 17.54 0.4069
2014-08-12 2014-06-30 13F Bristol-Myers COM 110122108 15,399 -3,475 -18.41 747 -23.85 0.3495
2014-05-08 2014-03-31 13F Bristol-Myers COM 110122108 18,874 -1,500 -7.36 981 -9.42 0.4562
2014-02-14 2013-12-31 13F Bristol-Myers COM 110122108 20,374 -1,325 -6.11 1,083 7.87 0.5019
2013-11-12 2013-09-30 13F Bristol-Myers COM 110122108 21,699 -4,650 -17.65 1,004 -14.70 0.5277
2013-08-14 2013-06-30 13F Bristol-Myers COM 110122108 26,349 26,349 1,177 0.6444
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.